NEXIEN BIOPHARMA, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Nexien Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2014 to 2024.
  • Nexien Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2024 was $10K.
  • Nexien Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $33.4K.
  • Nexien Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $174K, a 77.6% increase from 2021.
  • Nexien Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $98K, a 717% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $33.4K Jul 1, 2023 Jun 30, 2024 10-K 2024-10-22
2022 $174K +$76K +77.6% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-28
2021 $98K +$86K +717% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-28
2020 $12K Jul 1, 2019 Jun 30, 2020 10-K 2021-10-12
2018 $1.5M +$1.48M +9377% Jul 1, 2017 Jun 30, 2018 10-K 2019-09-30
2017 $15.8K -$522 -3.19% Jul 1, 2016 Jun 30, 2017 10-K 2017-07-31
2016 $16.4K -$30.4K -65% Jul 1, 2015 Jun 30, 2016 10-K 2017-07-31
2015 $46.7K +$46.3K +10284% Jul 1, 2014 Jun 30, 2015 10-K 2016-09-28
2014 $450 Jul 1, 2013 Jun 30, 2014 10-K 2015-09-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.